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Abstract
Functional recovery from central neurotrauma, such as spinal cord injury, is limited by mye-
lin-associated inhibitory proteins. The most prominent example, Nogo-A, imposes an inhibi-
tory cue for nerve fibre growth via two independent domains: Nogo-A-Δ20 (residues 544–
725 of the rat Nogo-A sequence) and Nogo-66 (residues 1026–1091). Inhibitory signalling
from these domains causes a collapse of the neuronal growth cone via individual receptor
complexes, centred around sphingosine 1-phosphate receptor 2 (S1PR2) for Nogo-A-Δ20
and Nogo receptor 1 (NgR1) for Nogo-66.Whereas the helical conformation of Nogo-66
has been studied extensively, only little structural information is available for the Nogo-A-
Δ20 region.We used nuclear magnetic resonance (NMR) spectroscopy to assess potential
residual structural propensities of the intrinsically disorderedNogo-A-Δ20. Using triple reso-
nance experiments, we were able to assign 94% of the non-proline backbone residues.
While secondary structure analysis and relaxationmeasurements highlighted the intrinsi-
cally disordered character of Nogo-A-Δ20, three stretches comprising residues 561EAI-
QESL567, 639EAMNVALKALGT650, and 693SNYSEIAK700 form transient α-helical
structures. Interestingly, 561EAIQESL567 is situated directly adjacent to one of the most con-
served regions of Nogo-A-Δ20 that contains a bindingmotif for β1-integrin. Likewise,
639EAMNVALKALGT650 partially overlaps with the epitope recognized by 11C7, a Nogo-A-
neutralizing antibody that promotes functional recovery from spinal cord injury. Diffusion
measurements by pulse-field gradient NMR spectroscopy suggest concentration- and oxi-
dation state-dependent dimerisationof Nogo-A-Δ20. Surprisingly, NMR and isothermal titra-
tion calorimetry (ITC) data could not validate previously shown binding of extracellular loops
of S1PR2 to Nogo-A-Δ20.
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Introduction
Neurons in the central nervous system (CNS) exhibit very limited capacity to regrow upon
neurotrauma, preventing them from restoring disrupted networks after a spinal cord or brain
injury. This is contrary to the situation in the peripheral nervous system (PNS), where
regrowth of nerve fibres can occur to a much higher extent [1, 2]. CNS-specificmyelin-associ-
ated inhibitorymolecules that actively prevent the outgrowth of neurons are an important fac-
tor accounting for this discrepancy [3].
One of the most prominent members of these inhibitorymolecules is the 1163 residues (rat
sequence) long membrane protein Nogo-A, also referred to as reticulon 4-A [4–6]. Nogo-A is
expressed on the surface of oligodendrocyteswhere it exhibits an inhibitory signal for neurite
growth [7, 8]. Nogo-A acts as a stabilizer for the highly complex CNS wiring; it restricts synap-
tic plasticity and influences various intracellular processes such as shaping of the endoplasmic
reticulum (ER), where particularly high Nogo-A levels are found [9–11]. Two domains of
Nogo-A have been identified that impose inhibitory effects on neurite growth and cell migra-
tion: Nogo-A-Δ20 and Nogo-66 [7]. The Nogo-A-Δ20 domain, which contains 182 residues, is
located in the middle of the 803 residues long Nogo-A-specific segment. In contrast, the 66 res-
idues long Nogo-66 domain is situated between two long hydrophobic stretches at the C-termi-
nus that Nogo-A shares with its much smaller isoforms Nogo-B and Nogo-C, as well as with
other reticulon proteins. Neurons express distinct receptors for each of these inhibitory
domains, i.e., sphingosine 1-phosphate receptor 2 (S1PR2) together with tetraspanin-3 for
Nogo-A-Δ20 and Nogo receptor 1 (NgR1) in association with co-receptors p75, Troy and
Lingo-1 for Nogo-66 [12–18]. S1PR2 and NgR receptor complexes both lead to an activation of
RhoA in the neuronal cytoplasm, which in turn causes destabilisation of the actin cytoskeleton
and thus collapse of the neuronal growth cone as well as a general downregulation of the neu-
ronal growth machinery [10].
Structural analysis at atomic resolution is a powerful approach to gain insight into the struc-
ture-activity relationship of proteins. To date, Nogo-66 is the only inhibitory domain of Nogo
for which a structure has been determined [19]. For Nogo-A-Δ20, it is only known that it
exhibits an overall unstructured conformation [20, 21]. However, according to circular dichro-
ism (CD) spectroscopy, this region seems to contain residual secondary structure [21]. This is
supported by secondary structure prediction indicating the presence of residual conformations
within the Nogo-A-Δ20 sequence [20, 22]. Furthermore, the addition of zinc ions to Nogo-A-
Δ20 induced a higher degree of α-helical content in circular dichroism [21]. However, the exact
locations of putative structural elements within Nogo-A-Δ20 have not been known until now.
The interaction betweenNogo-A-Δ20 and the G-protein coupled receptor S1PR2 has been
demonstrated biochemically and functionally [12]. Extracellular loops (ECLs) 2 and 3 of
S1PR2 were concluded to be the primary binding sites for Nogo-A-Δ20, based on the nanomo-
lar affinities of isolated ECL peptides in a microscale thermophoresis assay. However, only little
is known about the exact binding mode and amino acid residues involved in this interaction.
Here, we provide first structural data of Nogo-A-Δ20 with single-residue resolution using
nuclear magnetic resonance (NMR) spectroscopy. The backbone of biologically active Nogo-
A-Δ20 was assigned to a completeness of 94% using various triple resonance experiments,
revealing three sites of marked α-helical propensity. A concentration-dependent dimerisation
was found using diffusionNMR experiments. In addition, we investigated the interaction of
S1PR2 with Nogo-A-Δ20 by titrating isolated ECL2 and ECL3 of S1PR2 to Nogo-A-Δ20. No
conclusive binding data were obtained for these isolated fragments using NMR spectroscopy
and isothermal calorimetry (ITC).
NMRStudies on a Nogo Fragment
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Results
Structural Propensities for Nogo-A-Δ20
Nogo-A-Δ20 was expressed as 13C- and/or 15N-labelled recombinant protein in E. coli to study
its structural characteristics using CD and NMR spectroscopy. The CD spectrumof Nogo-A-
Δ20 with its minimum at around 200 nm suggests a high proportion of unstructured regions,
with some residual secondary structure (Fig 1). Addition of dodecylphosphocholine (FC12),
which is required for structuring of Nogo-66 [19], only led to minor changes in the CD spec-
trum of Nogo-A-Δ20, indicating that FC12 induced no significant structural rearrangements.
In accordance with the CD spectrumobserved for Nogo-A-Δ20, a 2D-NMR [15N,1H]-
HSQC spectrumconfirmed the intrinsically disordered character of Nogo-A-Δ20, as deduced
from the low chemical shift dispersion in the 1H dimension (Fig 2A). In order to obtain
sequence-specificconformational and structural information, a backbone assignment was con-
ducted. Standard pulse programs (HNCA, HNCACB) and non-standard experiments (HNN
and HCAN) were recorded on [13C, 15N]-Nogo-A-Δ20. The low dispersion in the proton
dimension, present in HNCA, HNCACB, and HNN spectra, together with many proline resi-
dues present in the sequence (13%, 23 prolines of 182 residues), interrupted the sequential
assignment and posed a severe challenge. To overcome the discontinuity of the spectra along
the backbone caused by proline residues, an HCAN spectrumwas recorded. Here, the magneti-
sation is transferred from 1Hα to 13Cα and further on to Ni and Ni+1, enabling a connection of a
proline to its following residue [23] and allowing a sequential assignment through prolines.
With this set of NMR experiments, 94% of the non-proline 13Cα and 13Cβ and 83% of proline
13Cα- and 13Cβ-frequencies in Nogo-A-Δ20 were assigned (Fig 2B). An unambiguous assign-
ment was impossible for the residue stretches 575PSFE578 and 678LIKETK683 due to severe peak
overlap (S1 Fig). The complete assignment can be found in Fig 2A and was deposited in the
BiologicalMagnetic Resonance Bank (BMRB) with the ID 26653.
The sequential assignment enables secondary structure analysis using secondary chemical
shifts of Δδ13Cα and Δδ13Cβ, which are the difference between the observed chemical shifts and
corresponding random coil chemical shifts (S2 Fig) [24]. Positive Δδ13Cα values and negative
Δδ13Cβ values for several consecutive residues indicate an α-helical conformation. Conversely,
negative Δδ13Cα in combination with positive Δδ13Cβ indicate the formation of a β-strand.
Fig 1. CD spectroscopy of Nogo-A-Δ20 at 25°C.Recombinant Nogo-A-Δ20 exhibits a spectrum typical for
unstructured proteins. Addition of FC12, thought to mimic a membrane environment, slightly enhances the
structural composition of the protein. However, the observed changes are negligible compared to the α-
helical structure reported for Nogo-66 upon FC12 addition [19]. Addition of ECL2 to Nogo-A-Δ20 in a
membrane-mimicking environment does not lead to folding, either.
doi:10.1371/journal.pone.0161813.g001
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These two experimental values can be combined with the secondary structure propensity (SSP)
algorithm resulting in a combined statistically more relevant value with positive values indicat-
ing α-helical and negative values suggesting β-strand conformations (Fig 3A) [25]. The SSP
score for each residue was calculated from 13Cα and 13Cβ chemical shifts and weighted over five
residues. Thereby, many residues of Nogo-A-Δ20 showed values close to zero (Fig 3A), indicat-
ing a random coil-like structure with little secondary structure elements [26–28]. However, the
three segments 561EAIQESL567, 639EAMNVALKALGT650, and 693SNYSEIAK700 contained
positive SSP values above 0.1 for more than five consecutive residues indicating α-helical pro-
pensity. These three stretches relate well to three α-helices that were predicted in silico by
PSIPRED v3.3 (residues 561–566, 637–648 and 696–700; S3 Fig) [22].
In order to corroborate the proposed helical propensity of the three segments, scalar cou-
plings 3JHNHα were measured. Secondary scalar couplings, Δ3JHNHα, were calculated by sub-
tracting random-coil values [29] from the experimentallymeasured 3JHNHα data. While
positive Δ3JHNHα values show a tendency for β-sheets, negative values indicate turns or α-
Fig 2. 2D [15N, 1H]-HSQCand some strips of 3D triple resonanceexperiments used for the sequential assignment of
Nogo-A-Δ20. A: Assigned [15N, 1H]-HSQCof Nogo-A-Δ20 following the numbering scheme of rat Nogo-A. The narrow chemical
shift dispersion is a common feature of intrinsically disorderedpolypeptides (IDPs).B: At the top, strips of the 3D HNCACB
spectrumare shown with green and orange contours indicating positive and negative cross peaks, respectively. At the bottom,
strips of the 3D HNN spectrumare shown with red and green contours indicating positive and negative cross peaks, respectively.
In the HNCACB, cross peaks belonging to Cα, Cαi-1, Cβ, and Cβi-1 are indicated, while in the HNN spectrum, the Ni, Ni-1, and Ni+1
are labelled. The HNCACB spectrumwas recorded at a 600MHz and the HNN spectrumwas recorded at a 700MHz NMR
spectrometer at 6°C and pH 7.4.
doi:10.1371/journal.pone.0161813.g002
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helical propensities [30]. All the three stretches proposed to be α-helical according to their sec-
ondary chemical shift values, i.e., 561EAIQESL567, 639EAMNVALKALGT650, and 693SNY-
SEIAK700, had negative Δ3JHNHα values supporting the presence of transient α-helices in these
segments (Fig 3B).
An independent measure of both disorder and secondary structure can be obtained by 15N
{1H}-heteronuclear NOEs (HetNOE). While positive values close to 1 indicate structural rigid-
ity of the backbone 15N-1H moieties, values close to 0 indicate dynamics in the range of ~1 ns,
and 15N-1H moieties with negative values are highly flexible with dynamics faster than ~1 ns
[31, 32]. Most of the values of Nogo-A-Δ20 were slightly positive between 0.1 and 0.2, and
extended runs of positive values were especially found at the locations of all three proposed α-
helical stretches (Fig 3C). In addition, the N- and C-terminal regions of Nogo-A-Δ20 showed
an elevated rigidity (Fig 3C). Overall, the HetNOE data indicate a highly flexible state for
Nogo-A-Δ20, as commonly found in IDPs [33, 34].
Clustering of Nogo-A-Δ20 and of full-lengthNogo-A is a highly discussed topic [7, 14, 35].
Pulse-field gradient NMR spectroscopy experiments were therefore recorded to determine the
diffusion coefficientD of Nogo-A-Δ20 at two different concentrations.D30 μM was found to be
2.18 ± 0.02×10-11 m2/s (mean ± SD), and D560 μM equalled 2.00 ± 0.01×10-11 m2/s (Fig 4). Since
two cysteines are present in Nogo-A-Δ20, we also tested the influence of their oxidation state
Fig 3. Secondary structureand flexibilityanalysis of Nogo-A-Δ20. A: Secondarystructurepropensities
for single residues. Three residual α-heliceswere found as defined by five or more consecutive residueswith
SSP values above 0.1 (yellow boxes). B: Δ3JHNHα derived from the difference between 3JHNHαmeasured
from intensitymodulated [15N,1H]-HSQCexperiments and corresponding random coil values [29]. Negative
Δ3JHNHα indicate an α-helical while positive values indicate an extended conformation, respectively. C: 15N
{1H}-HetNOEs. A value near 1 indicates a fully rigid conformation, values close to zero indicate the presence
of ~1 ns dynamics, while negative values indicate the presence of even faster motion.Most of the values are
positive between the ratios 0.1–0.2.Only two consecutive strands between the residues 580–588 and 603–
614 have negative values. Error bars were calculated using Gaussian error propagation. The locations and
secondary structure propensity of α-helices as determined by NMR (see text) are indicated above the
diagrams. The cylinders/yellow boxes indicate transientα-helical propensities. Residues belonging to the
affinity tags flankingNogo-A-Δ20 are not plotted.
doi:10.1371/journal.pone.0161813.g003
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on the diffusion coefficient.Dred30 μM in the presence of the reducing agent tris (2-carbox-
yethyl) phosphine (TCEP) was increased to 2.53 ± 0.01×10-11 m2/s, and Dred560 μM to
2.55 ± 0.02×10-11 m2/s (Fig 4). These results indicate that Nogo-A-Δ20 dimerises under non-
reducing conditions, although no significant chemical shift changes in 2D [15N, 1H]-HSQC
NMR spectra could be observed (S4 Fig).
Titration of S1PR2 Fragments to Nogo-A-Δ20
It has been shown that Nogo-A-Δ20 binds to isolated extracellular loops (ECL) 2 and 3 of
sphingosine 1-phosphate receptor 2 (S1PR2) with affinities in the nanomolar range [12]. In
order to identify the binding interface between ECL peptides and Nogo-A-Δ20 at atomic reso-
lution, ligand titration studies were performed using NMR spectroscopy.
First, ECL2 was titrated to 15N-labeledNogo-A-Δ20 at different molar ratios. A [15N, 1H]-
HSQC spectrumwith a resolution of 0.04 ppm in the 15N and 0.028 ppm in the 1H dimension
was measured for each titration step at 6°C and pH 7.4 including a reference without addition
of ECL2 (Fig 5 and S5 and S6 Figs). Even with a threefold excess of ECL2, no cross peak shifts
were detectedwhen compared to the spectrumwithout ECL2 (Fig 5B and S5C Fig). Normal-
ized chemical shift changes of the combined 15N and 1H residues of Nogo-A-Δ20 were smaller
than 0.005 ppm. These values were below the combined 15N and 1H detection resolution of
0.07 ppm, indicating the absence of conformational changes upon ECL2 addition. Since pro-
nounced chemical shift changes were observed for several peaks of Nogo-A-Δ20 upon
decreased pH (S7 Fig), it was hypothesised that a lower pHmight be necessary for binding.
However, a reduction of pH from 7.4 to 6.4 did not result in any peak shifts upon ECL2 titra-
tion (S6A and S5B Figs). Furthermore, a temperature increase from 6°C to 15°C to match the
conditions of a previously published binding study more closely [12] did not result in any peak
shifts upon ECL2 titration (S5D and S6B Figs). Subsequently, Nogo-A-Δ20 was investigated
upon ECL3 titration. Similarly, no peak shifts could be detected (Fig 5C and S8A Fig). ECL3
titration also did not perturb the [15N, 1H]-HSQC spectra of Nogo-A-Δ20 in the presence of 5
mMTCEP, suggesting no dependence of binding on the oxidation state of Nogo-A-Δ20 cyste-
ines (S6C Fig). Since the presence of zinc increases the α-helical content of Nogo-A-Δ20 [21], 4
Fig 4. NMRdiffusion experiments on Nogo-A-Δ20. Logarithmic intensities of Nogo-A-Δ20 at different
conditions were plotted against its dependence on gradient strength.Nogo-A-Δ20 was measuredwith pulsed
field gradient experiments at two concentrations (30 and 560 μM), shown as closed circles and squares,
respectively. The diffusion coefficientwas calculated according to [36], resulting inD30 μM = 2.18 ± 0.02×10-11
m2/s andD560 μM = 2.00 ± 0.01×10-11 m2/s (mean ± SD). Nogo-A-Δ20 was measured again in the presence of
the reducing agent TCEP, shown as open circles (30 μM) and squares (560 μM). Here, the diffusion
coefficients equalledDred30 μM = 2.53 ± 0.01×10-11 m2/s andDred560 μM = 2.55 ± 0.02×10-11 m2/s. ***,
p < 0.0001; ns, not significant; red, reduced.
doi:10.1371/journal.pone.0161813.g004
NMRStudies on a Nogo Fragment
PLOSONE | DOI:10.1371/journal.pone.0161813 September 9, 2016 6 / 19
mM zinc ions were added to the sample. Again, no changes in the spectra could be detected
upon ECL3 addition, indicating that zinc ions do not facilitate ECL binding (S6D and S8B
Figs). Finally, as FC12 is required for folding of Nogo-66 [19], we explored the possibility that
Nogo-A-Δ20 only binds to ECL2 in the presence of FC12. However, no changes in the Nogo-
A-Δ20 CD spectrumwere observedwhen ECL2 was added in the presence of FC12 (Fig 1). The
missing shifts of [15N,1H]-HSQCpeaksmight be explained by an intermediate exchange of the
bound and unbound state. In this time regime, decreases of intensities of the amino acid resi-
dues participating in an interaction are anticipated. Therefore, the intensity ratios of Nogo-A-
Δ20 in the presence vs. absence of ECL2 and ECL3 were calculated for each residue (Fig 6 and
Fig 5. Chemical shift perturbationsupon titrationof ECLs of S1PR2 to Nogo-A-Δ20.Nogo-A-Δ20
chemical shift difference (CSD) of the combined 15N and 1H chemical shifts between free Nogo-A-Δ20 and
Nogo-A-Δ20 in presence of ECLs.A: 1 to 1 ratio (ECL2) at pH 7.4 and 6°C. B: 1 to 3 ratio (ECL2) at pH 7.4
and 6°C. C: 1 to 3 ratio (ECL3) at pH 7.4 and 6°C. The chemical shift differences are smaller than 0.005 ppm
indicating no chemical shift changes of Nogo-A-Δ20 protein upon ligand titration.
doi:10.1371/journal.pone.0161813.g005
Fig 6. Intensity ratios between Nogo-A-Δ20 in the presence vs. absenceof ECLs. A: 1 to 1 ratio (ECL2)
at pH 7.4 and 6°C. B: 1 to 3 ratio (ECL2) at pH 7.4 and 6°C. C: 1 to 3 ratio (ECL3) at pH 7.4 and 6°C. The
values are corrected for the volume decrease upon ligand titration.Minor deviations from 1 can be explained
by imperfectly tuned pH and temperature. Error bars were calculated using Gaussian error propagation.
doi:10.1371/journal.pone.0161813.g006
NMRStudies on a Nogo Fragment
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S9 Fig). The intensity ratios at pH 7.4 at 6°C were found to have a random distribution near 1
for the Nogo-A-Δ20 to ECL2 ratios of 1 to 1 and 1 to 3, indicating no intermediate exchange.
Intensity ratios at pH 6.4 at 6°C and at pH 7.4 at 15°C upon addition of ECL2 and the intensity
ratio at pH 7.4 at 6°C upon addition of ECL3 have a larger deviation from the value 1, which
might be rather attributed to an imperfect adjustment of pH and temperature than to ECL
binding.
IsothermalTitrationCalorimetry(ITC)
A third biophysical technique, ITC, was consulted to investigate the discrepancy between
NMR spectroscopy and previous binding assay data [12]. Either ECL2 or ECL3 were titrated to
10 μMNogo-A-Δ20. In both cases, only very small exothermic heat signals could be detected
upon titration (S10 Fig). For ECL2, a small difference in the heat signals at low and high con-
centration could be observed. Furthermore, equally-sized heat signals were observed through-
out the titration for ECL3.
Cellular Activity Assay for Nogo-A-Δ20
In order to confirm that the obtained structural data correspond to a biologically active protein,
and in order to exclude that the lack of peak shifts upon ECL titration was due to misfolding of
Nogo-A-Δ20, we performed a 3T3 fibroblast spreading assay (Fig 7). Fibroblast spreading was
markedly inhibited on isotopically labelledNogo-A-Δ20 substrate, confirming intact inhibitory
activity of the protein. Importantly, the IC50 value was ~40 pmol/cm2, which is a typical
potency for Nogo-A-Δ20-induced inhibition of 3T3 fibroblast spreading [37].
In summary, Nogo-A-Δ20 is an intrinsically disordered domain as indicated by CD data,
[15N, 1H]-HSQCpeak dispersion, secondary chemical shift analysis and dynamic studies.
Within the disordered region, three contiguous segments of α-helical propensity are found. All
agree well with those indicated by a computational algorithm. Diffusion coefficients of Nogo-A-
Δ20 suggest a dimerisation dependent on the concentration and oxidation state of the protein.
Fig 7. Activity assay of 13C, 15N-labelledNogo-A-Δ20. 3T3 fibroblasts were plated on Nogo-A-Δ20 or
control substrate for 1 h and fixed with paraformaldehyde. Non-linear regression reveals an IC50 value of ~40
pmol/cm2. Mean cell size ± standard deviation from threewells is shown for each concentration.
doi:10.1371/journal.pone.0161813.g007
NMRStudies on a Nogo Fragment
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While titration of ECL2 and ECL3 to Nogo-A-Δ20 did not induce pronounced peak shifts in
[15N,1H]-HSQC spectra or show marked thermal heat exchange in ITCmeasurements, the used
batch of Nogo-A-Δ20 was found to be active in a 3T3 fibroblast spreading assay.
Discussion
We investigated Nogo-A-Δ20 using CD and NMR spectroscopy. We were able to obtain high-
quality NMR spectra for backbone assignment, which enabled us to derive structural data with
atomic resolution. Our data show a high degree of disorder within the neurite growth and cell
spreading inhibitory Nogo-A-Δ20 region. The largely random coil CD spectrumand narrow
proton dispersion in [15N, 1H]-HSQC spectra confirm previous observations [20, 21] and are
extended by the experimentally obtained secondary structure analysis of secondary chemical
shifts, 3JHNHα scalar coupling, as well as the high degree of flexibility indicated by HetNOE
measurements. Importantly, despite the lack of fully structured regions, isotopically labelled
and thrombin-cleaved Nogo-A-Δ20 exerted its typical inhibitory activity in a 3T3 fibroblast
spreading assay.
Structural flexibility imposes a variety of advantages on proteins, ranging from an enlarged
interaction surface and thus higher binding specificity to an elevated promiscuity towards
binding partners [38–40]. As a consequence, IDPs are involved in a multitude of signalling
pathways and appear in all three domains of life, i.e., Archaea, Bacteria, and Eukarya [41]. The
intrinsically disordered Nogo-A-Δ20 has been shown to interact with various binding partners,
such as S1PR2, tetraspanin-3, β1-integrins, cyclic nucleotide phosphodiesterase, and WWP1
[12, 13, 42–45]. In addition, clustering of N-terminal Nogo-A fragments including Nogo-A-
Δ20 has been described to enhance their inhibitory potency [14, 42]. Our finding that the diffu-
sion coefficient of Nogo-A-Δ20 is reduced at higher concentrations supports the notion of
dimer formation. A high degree of flexibility might represent an important structural feature of
this domain, increasing its surface area available for binding molecular target proteins and for
homodimerisation.Additionally, Nogo-A is a multifaceted player implicated in neurite out-
growth inhibition, CNS development, synaptic plasticity, ER membrane morphology, and sev-
eral other processes by interactions with several binding partners and multisubunit receptors
[10, 46, 47]. Structural disorder could therefore allow different sets of interactingmolecules to
bind to the same sites within Nogo-A-Δ20 depending on the context, a model referred to as
functionalmoonlighting [48].
Although no fully structured regions were found, we identified three segments within
Nogo-A-Δ20 that appear to form transient and dynamical α-helical structures: 561EAIQESL567,
639EAMNVALKALGT650, and 693SNYSEIAK700. All of these regions seem to be α-helical
based on their positive SSP and negative Δ3JHNHα values, and they exhibit decreased flexibility
as determined by HetNOE. Similar results were obtained for the very C-terminal four residues
of Nogo-A-Δ20 (residues 722–725), which might represent the beginning of another α-helix in
full-lengthNogo-A. At the N-terminal boundary of Nogo-A-Δ20 (residues 548–560), flexibility
is also reduced. However, the secondary structure of this region could not be determined
unambiguously by SSP and Δ3JHNHα evaluation.
Significant residual secondary structures are commonly found in IDPs, and they often
resemble structural characteristics present in the bound state [49–53]. It has therefore been
suggested that these residual structures are involved in initial molecular recognition [51, 52].
One could speculate that the α-helical structures found in Nogo-A-Δ20 also serve as such rec-
ognition sparks, forming initial contact with binding partners. Adjacent unstructured regions
could then confer higher specificity to the interaction. Strikingly, 561EAIQESL567 is located in
direct juxtaposition with one of the most conserveddomains of Nogo-A-Δ20 (residues 554–
NMRStudies on a Nogo Fragment
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559) that harbours a β1-integrin binding motif (S1 Fig) [43]. Similarly, 639EAMNVALK-
ALGT650 partially overlaps with the binding epitope for the Nogo-A-neutralizing antibody
11C7 (residues 630–640) that has been shown to enhance recovery from spinal cord injury in
rats and macaques [54, 55].
Forced dimerisation of Nogo-A-Δ20 has been reported to enhance the inhibitory properties
of the protein [7, 14]. The markedly elevated diffusion coefficients in the presence of TCEP
support dimerisation through the formation of disulphide bridges of Nogo-A-Δ20 in a non-
reducing environment. Dimerisation seems to be concentration dependent, as the diffusion
coefficient of Nogo-A-Δ20 in the absence of TCEP decreased at higher concentrations of
Nogo-A-Δ20. A larger fragment of human Nogo-A that contained Nogo-A-Δ20 has been
shown to co-exist in two disulphide isomers by non-reducing SDS/PAGE [35]. Electrophoretic
mobility was enhanced in each of these disulphide isomers as compared to the reduced frag-
ment, indicating that both isomers harbour intra-molecular disulphide bridges. By mutational
analysis, the authors were able to identify four conserved cysteines that are involved in this pro-
cess, though the exact connectivity remains elusive [35]. Of these conserved cysteines, only one
(corresponding to rat Cys574) is located within Nogo-A-Δ20, indicating a possible intra-
molecular disulphide bond with a cysteine outside of Nogo-A-Δ20. In the isolated Nogo-A-
Δ20 fragment, this unpaired cysteine could contribute to non-physiological inter-molecular
disulphide bridges resulting in dimerisation. Alternatively, it is possible that the second cyste-
ine within Nogo-A-Δ20, Cys676, accounts for this observation, though it seems dispensable for
overall folding [35].
Oxidation state-dependent dimerisation could be of physiological relevance for Nogo-A sig-
nalling. In order to impose its inhibitory effect on passing neurons, Nogo-A-Δ20 is presented
on the surface of oligodendrocytes,where it is exposed to the oxidising environment of the
extracellular space [5, 7]. On the other hand, a different membrane topology is found at the
ER, where Nogo-A-Δ20 faces the reducingmilieu of the cytosol [7, 11]. It can therefore be spec-
ulated that the oxidation state of Nogo-A-Δ20 at different cellular compartments contributes
to its diverse functions, possibly through differential disulphide bonding and/or dimerisation.
The connectivity of disulphide bridges in Nogo-A, as well as their individual contributions to
folding, dimerisation, S1PR2 binding and inhibitory activity, will be the subject of future sys-
tematic mutational studies.
No chemical shift perturbations could be observedupon titration of ECL peptides, and only
very small exothermal signals were detectedwith ITC suggesting no specific high affinity bind-
ing. This is surprising, as ECL2 and ECL3 had been shown to bind Nogo-A-Δ20 with KD values
of ~280 nM and ~350 nM, respectively, by microscale thermophoresis [12]. Microscale ther-
mophoresis determines the diffusion coefficient of a labelledmolecule as a function of the con-
centration of its binding partner. The diffusion coefficient is susceptible to various parameters
such as buffer composition or size, charge, hydration shell or conformation of a molecule [56].
Therefore, not only molecular interactions are measured via microscale thermophoresis, but
also conformational alterations or charge variations caused by slight changes in the buffer con-
ditions within the titration experiment such as pH, which do not have to be induced by ligand
binding. On the other hand, it should be noted that isolated ECLs are likely to assume different
conformations than in the context of the whole GPCR. The physiologically relevant structure
presumably depends on the relative positions of adjacent hydrophobic regions. Likewise,
Nogo-A-Δ20 only represents a fragment of Nogo-A that might not include all structural fea-
tures required for a physiological interaction. Future structural investigations should therefore
concentrate on the full-lengthNogo-A and S1PR2 proteins.
In conclusion, we have shown that biologically active Nogo-A-Δ20, while unstructured in
the majority of its sequence, contains three stretches with α-helical propensity. Whereas α-
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helices could be involved in initial recognition and presentation of disordered regions, struc-
tural flexibility of Nogo-A-Δ20 might be essential for specific interactions with the binding
partners in cellular membranes, neuritic growth cones, at CNS synapses, and in the ER.We
provide further evidence that dimerisation occurs in Nogo-A-Δ20, the physiological relevance
of which needs to be further investigated. However, we could not detect structural changes of
Nogo-A-Δ20 upon titration of isolated ECL2 or ECL3 by NMR spectroscopy, and only minor
thermal heat exchanges were observedby ITC. It will be fascinating to gain more insight on the
structural basis of this clinically highly relevant signalling node.
Material andMethods
Expression of Isotopically Labelled Nogo-A-Δ20
Rat Nogo-A-Δ20 (residues 544–725) was cloned into the pET28 vector containing a His6-tag at
each terminus and a T7-tag between the N-terminal His6-tag and Nogo-A-Δ20 [7]. 15N- or
13C,15N-labelledNogo-A-Δ20 was expressed in One Shot BL21 (DE3) strain of E. coli in M9
minimal mediumwith max. 4 g/L D—glucose-13C6 (13C> 99%) or 8 g/L D-glucose-12C6 and
1 g/L 15N-ammonium chloride (15NH4Cl, 15N> 98%) purchased from Sigma-Aldrich (Buchs,
Switzerland). Bacteria were grown at 37°C at 100 rpm until the OD590 reached 1.2, transferred
to 30°C and induced with 1 mM IPTG. The fusion protein was expressed for 8 hours and cells
were harvested by centrifugation. The wet pellet was stored at -80°C.
Purificationof Nogo-A-Δ20
All of the following purification steps were performed at 4°C. A frozen pellet of 1 L of bacterial
culture was thawed on ice and resuspended in 50 mL lysis buffer (20 mMNaH2PO4, 500 mM
NaCl, 20 mM imidazole, pH 7.4). 0.5 mg/mL lysozyme, 0.5 mM PMSF, and 1 protease inhibi-
tory tablet (Roche Diagnostics GmbH, Mannheim, Germany) were added. The lysate was stir-
red for 20 min. Cells were further disrupted by passing twice through a 110S microfluidizer
(Microfluidics, Newton, Massachusetts, USA) at 40 PSI. The suspension was centrifuged at
40'000 rpm (125171 g) for 30 min (Optima L-90K Ultracentrifuge, rotor Ti-45, BeckmanCoul-
ter International, S.A., Nyon, Switzerland) to pellet cellular debris [7]. The supernatant of the
centrifugationwas bound to 3 mL Ni-NTA Agarose fromQiagen (Merck KGaA, Darmstadt,
Germany) via batch mode during 2 h. The Ni-NTA was washed with 30 mL lysis buffer, eluted
with ca. 5 mL elution buffer (20 mMNaH2PO4, 500 mMNaCl, 500 mM imidazole, pH 7.4) via
gravity flow and collected in 0.5 mL fractions. The elution buffer was exchanged to PBS buffer
with a pre-packed and disposable PD-10 desalting column (GE Healthcare Life Sciences, Buck-
inghamshire, UK). To remove the N-terminal His6-tag, bovine thrombin (Sigma-Aldrich,
Buchs, Switzerland) was added to the desalted sample with the ratio of 2 NIH units of thrombin
per ca. 1 mg desalted Nogo-A-Δ20 for 1 hour. The cleaved fusion protein was purified on a
Highload™ 26/60, Superdex™ 75 column using an Äkta FPLC system (prep grade, GE Health-
care, Uppsala, Sweden).
To exclude batch-to-batch variations, 6 L of 15N-labelledNogo-A-Δ20 were expressed, puri-
fied, shock frozen in aliquots, and finally stored at -80°C until usage for ECL titration.
CD spectroscopy
CDmeasurements were carried out on a Jasco J815. The spectra were scanned from 260–198
nm at 20 nm/min with 1 nm band-pass, 4 seconds integration and averaged over 2 repetitions.
The measurements of Nogo-A-Δ20 were executed in PBS at 25°C with a concentration of
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10 μM. Dodecylphosphocholine(FC12; Affymetrix, Santa Clara, CA, USA) and ECL2 (see
NMR section) were added to final concentrations of 6.67 mM and 10 μM, respectively.
NMR spectroscopy
The concentration of isotopically labelledNogo-A-Δ20 for the NMRmeasurements was
between 80–400 μM in PBS buffer containing 95% H2O and 5% D2O at pH 7.4. The experi-
ments were recorded on 600 MHz, 700 MHz, or 900 MHz Bruker NMR spectrometers (Bruker
BioSpin AG, Fällanden, Switzerland) equipped with either TCI or TXI cryoprobes. For the
amino acid sequence assignment, a [15N, 1H]-HSQC and a set of four triple-resonance experi-
ments were measured at 6°C. The chemical shifts of the amide proton, the amide nitrogen, the
13Cα and 13Cβ were obtained using the triple-resonance experiments HNCA (80[F3] × 80[F2]
× 1024[F1] complex data points, 16 number of scans, 0.8 s relaxation delay, WATERGATE for
water suppression and gradient pulses) [57] and HNCACB (100[F3] × 80[F2] × 1024[F1] com-
plex data points, 32 number of scans, 1 ms relaxation delay, preservation of equivalent path
(PEP) sensitivity enhancement and gradient pulses) [58]. Additionally, an HNN spectrumwas
recorded connectingNi to Ni-1 and Ni+1 (1024[F3] × 144[F2] × 256[F1] complex data points,
16 number of scans, 1 s relaxation delay with gradient enhancement) [59]. To correlate 1Hα to
13Cα and to Ni and Ni-1, a HCAN spectrum(124[F3] × 114[F2] × 1024[F1] complex data
points, 16 number of scans, 1 s relaxation delay) using PEP was recorded [23], enabling assign-
ment through proline residues.
The difference of the chemical shifts of the measured δ13Cα and δ13Cβ and random coil val-
ues [60] were calculated for the secondary chemical shift analysis. Composite values of Δδ13Cα
and ΔδCβ were calculated using the SSP algorithm from Forman-Kay group [25]. The algo-
rithm combines individual contributions of chemical shifts regarding their sensitivity to α- and
β-structure from different nuclei into a score. Hereby, the observed chemical shift differences
of a residue are weighted against the expected chemical shift differences for a secondary struc-
ture. To minimize contributions from chemical shifts that are poormeasures of secondary
structures, e.g., glycines, the algorithm additionally averages the score over five residues. The
final score of a residue ranges from 1 to -1, indicating fully formed α-helical or β-strand confor-
mations, respectively.
An intensity modulated [15N, 1H]-HSQC [61] was measured to obtain the 3JHNHα scalar
couplings (16 number of scans, 1 s relaxation delay, 2 τ = time for evolution of 3JHNHα: 18 ms).
The intensity ratios of the relation Im/Id = cos(π(3JHNHα)2 τ) were used for the calculation of
the coupling constant 3JHNHα, Im being the intensity of the modulated spectra and Id that of
decoupled ones. The experimentally obtained 3JHNHα was multiplied by a correction coefficient
of the magnitude of 1.06 due to the different relaxation properties of the in- and antiphase
magnetisation of the HN compared to the Hα [61]. The secondary scalar couplings, Δ3JHNHα,
were calculated by subtracting the corresponding random-coil values [29] from the experimen-
tally measured 3JHNHα data.
Dynamics of Nogo-A-Δ20 were examined with a 15N{1H}-HetNOE experiment (8 number
of scans, 6 s relaxation delay) [32]. The HetNOE was estimated by dividing IS, the intensity of
the saturated spectrum,by IU, the intensity of the corresponding peak in the unsaturated spec-
trum. Error bars for the HetNOE plot were calculated using Gaussian error propagation [62].
To determine the diffusion coefficient of reduced and unreducedNogo-A-Δ20, pulsed field
gradient experiments [36] were measured (30[F2] × 16384[F1] complex data points, gradient
between 5–75%, Δ of 200 ms, δ of 5.5 ms, 32 or 128 number of scans, 10 s relaxation delay,
WATERGATE for water suppression). The sample constituted of either 560 μM in absence or
presence of 2 mM tris(2-carboxylethyl)phosphinehydrochloride (TCEP, Sigma-Aldrich,
NMRStudies on a Nogo Fragment
PLOSONE | DOI:10.1371/journal.pone.0161813 September 9, 2016 12 / 19
Buchs, Switzerland) or 30 μM in absence or presence of 5 mM TCEP at pH 7.4 and 6°C. The
experimental data points were fitted according to [36]. Gradient strength was calibrated with
H2O, for which coefficient is known [63, 64]. Linear regression and an statistical analysis of the
slope differences were performed in Prism 5 (GraphPad Software, La Jolla, CA, USA), which
follows a calculationmethod that is equivalent to ANCOVA [65].
For the ECL titration, [15N,1H]-HSQC experiments were measured with a resolution of at
least 300[F2] × 2048[F1] with a maximal evolution time of 82 ms and 114 ms for 15N and 1H
frequencies, yielding a resolution of 0.04 ppm and 0.028 ppm, respectively. The combined 15N
and 1H resolution was 0.07 ppm. ECL2 (peptide sequenceNCLNQLEACSTVLPLYAKHYVL)
and ECL3 (SILLLDSTCPVRACPVLYK)were purchased from JPT Peptide Technologies
GmbH (Berlin, Germany). The concentration used for 15N-labeledNogo-A-Δ20 was 30 μM,
88 μM or 120 μM and the following molar ratios were measured: Nogo-A-Δ20: ECL2: 1: 1 and
1: 3, Nogo-A-Δ20: ECL3: 1: 3. The sample for ECL2 titration was measured at different pH val-
ues (pH 7.4 and 6.4) and different temperatures (6°C and 15°C). The Nogo-A-Δ20 sample for
the ECL3 titration was measured at pH 7.4 at 6°C in the presence or absence of either 5 mM
TCEP or 4 mM ZnCl2. The chemical shift differences (CSD) between the peaks of Nogo-A-Δ20
alone and those in presence of an ECL in the [15N, 1H]-HSQCwere calculated using the follow-
ing equation [66]:
CSD ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
0:5 ½ð1HA  
1HTÞ
2
þ 0:14 ð15NA  
15N TÞ
2

q
where 1HA and 1HT are the 1H chemical shifts of Nogo-A-Δ20 alone and in the presence of
ECL, and 15NA and 15NT are the 15N chemical shifts of Nogo-A-Δ20 alone and in the presence
of ECL. Additionally, the combined resolution of 1H and 15N was calculatedwith this equation
by inserting the 1H and 15N resolution instead of the chemical shift difference for 1H and 15N,
respectively. The spectra were processed with Topspin 3.1 (Bruker) before analysis. The amino
acid residue assignment was accomplished using the CcpNmr software [67].
IsothermalTitrationCalorimetry(ITC)
Nogo-A-Δ20, as well as ECL2 and ECL3 of S1PR2 were dialysed against PBS (pH 7.4) at 4°C
overnight. ITC experiments were carried out at 25°C on a MicroCal VP-ITC instrument (Mal-
vern Instruments, Worcestershire, UK) with a cell volume of 1400 μL and a syringe volume of
300 μL. Each experiment consisted of an initial injection of 2 μL, followed by 29 injections of
10 μL. Stirring speed was 300 rpm. Nogo-A-Δ20 was 10 μM in the cell, whereas ECL peptides
were 150 μM in the syringe. All data were analysed with the Origin software supplied by the
manufacturer.
3T3 Fibroblast SpreadingAssay
Four-well plates (Greiner BioOne GmbH, Frickenhausen, Germany) were coated overnight at
4°C with a dilution series of [13C, 15N]-labelledNogo-A-Δ20 in PBS, ranging from 0 to 100
pmol per cm2 growth area. The next day, wells were washed three times with PBS. NIH 3T3
fibroblasts (ATCC, Wesel, Germany) were briefly trypsinised,plated on Nogo-A-Δ20 or plastic
control substrate at 7’000 cells per cm2, and incubated for 1 h at 37°C and 5% CO2. Cells were
fixed with warm 4% paraformaldehyde (Sigma-Aldrich, Buchs, Switzerland) in PBS for 20 min
at RT, and washed three times with PBS at RT. Permeabilisation/blocking buffer [2% normal
goat serum (Jackson Laboratories,ME, USA), 0.2% Triton-X100 (AppliChem, Darmstadt, Ger-
many), 0.004% fish skin gelatine (Sigma-Aldrich, Buchs, Switzerland) in PBS at pH 7.4] was
added for permeabilisation at 4°C overnight. Cells were then incubated with DAPI (1:1000,
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Life Technologies, Carlsbad, CA, USA) and Alexa Fluor 488-labelled phalloidin (1:100, Life
Technologies, Carlsbad, CA, USA) in permeabilisation/blockingbuffer for 1 h at RT to stain
nuclei and the actin cytoskeleton, respectively. Finally, cells were washed three times with PBS
and coverslipped in fluorescencemounting medium (Dako Schweiz AG, Baar, Switzerland).
An Axioskop 2 mot plus fluorescencemicroscope (Carl Zeiss AG, Feldbach, Switzerland) was
used for automatic acquisition of DAPI and phalloidin images for 28 positions in each well.
CellProfiler software was employed to measure the sizes of only non-clumped cells [68].
Finally, non-linear regression was performed in Prism 5 (GraphPad Software, La Jolla, CA,
USA).
Supporting Information
S1 Fig. Sequential backbone assignment of Nogo-A-Δ20. Assigned residues are designated in
black, unassigned ones in grey. Bold type indicates the Nogo-A-Δ20 segment; the T7-tag and
the His6-tag are indicated in lowercase. 94% of the non-proline δCα frequencies within the 182
amino acid residues of Nogo-A-Δ20 were assigned. Residues with transient α-helical confor-
mations according to the combined secondary chemical shift values are highlighted in yellow.
Amino acid residues are numbered as found in the rat Nogo-A protein.
(EPS)
S2 Fig. Secondarychemical shift analysis.Δδ13Cα and Δδ13Cβ are shown individually in red
and blue. Stretches of positive Δδ13Cα and negative Δδ13Cβ, indicating α-helical propensity, are
found at residues 561EAIQESL567, 639EAMNVALKALGT650, and 693SNYSEIAK700.
(EPS)
S3 Fig. PSIPRED v3.3 secondarystructure prediction for Nogo-A-Δ20. Severalα-helical
domains and two β-strands are predicted with different confidence scores. Especially the α-
helices around amino acid residues 563, 643 and 697 have elevated likeliness to occur.
(EPS)
S4 Fig. [15N, 1H]-HSQC spectraof 560 μMNogo-A-Δ20 alone and in the presence of 2 mM
TCEP at pH 7.4 and 6°C. Spectrumof Nogo-A-Δ20 alone is shown in red contours, while the
spectrumupon addition of TCEP is in blue. The spectra revealed no marked chemical shift dif-
ferences in the presence and absence of TCEP.
(EPS)
S5 Fig. [15N, 1H]-HSQC spectraof 88 μMNogo-A-Δ20 alone and in the presence of ECL2
at different pH values and temperatures. For each subfigure, the spectrumof Nogo-A-Δ20
alone is shown in red contours, while the spectrumupon addition of an ECL fragment is colour
coded in blue. A: Nogo-A-Δ20 to ECL2 ratio of 1 to 1 at pH 7.4 and 6°C. B: Nogo-A-Δ20 to
ECL2 ratio of 1 to 1 at pH 6.4 and 6°C.C: Nogo-A-Δ20 to ECL2 ratio of 1 to 3 at pH 7.4 and
6°C.D: Nogo-A-Δ20 to ECL2 ratio of 1 to 3 at pH 7.4 and 15°C. No significant peak shifts
occurredupon ECL2 titration.
(EPS)
S6 Fig. Chemical shift perturbations upon titration of ECLs of S1PR2 to Nogo-A-Δ20.
Nogo-A-Δ20 chemical shift difference (CSD) of the combined 15N and 1H chemical shifts
between free Nogo-A-Δ20 and Nogo-A-Δ20 in presence of ECLs.A: 1 to 1 ratio (ECL2) at pH
6.4 and 6°C. B: 1 to 3 ratio (ECL2) at pH 7.4 and 15°C.C: 1 to 3 ratio (ECL3) at pH 7.4 and 6°C
in the presence of 5 mM TCEP. D: 1 to 3 ratio (ECL3) at pH 7.4 and 6°C in the presence of 4
mM zinc ions. The chemical shift differences are smaller than 0.005 ppm indicating no
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chemical shift changes of Nogo-A-Δ20 protein upon ligand titration.
(EPS)
S7 Fig. [15N, 1H]-HSQCof Nogo-A-Δ20 at pH 7.4 and 6.4 at 6°C. Red spectrumcorresponds
to Nogo-A-Δ20 at pH 7.4 and the green spectrumat pH 6.4. When comparing the spectra at
pH 7.4 and 6.4, pronounced chemical shifts are observable.
(EPS)
S8 Fig. [15N, 1H]-HSQCof 120 μMNogo-A-Δ20 alone and in the presence of ECL3 at pH
7.4 and 6°C. A: Nogo-A-Δ20 to ECL3 ratio of 1 to 3 at pH 7.4 and 6°C. B: Nogo-A-Δ20 to
ECL3 ratio of 1 to 3 at pH 7.4 and 6°C in the presence of 4 mM zinc ions. Pink and green spec-
trum:Nogo-A-Δ20 alone and in the presence of zinc, respectively; blue and purple spectrum:
Nogo-A-Δ20 in the presence of ECL3 and additionally zinc. No significant peak shifts occurred
upon ECL3 titration in the presence or absence of zinc ions.
(EPS)
S9 Fig. Intensity ratios betweenNogo-A-Δ20 in the presence vs. absence of ECLs. A: 1 to 1
ratio (ECL2) at pH 6.4 and 6°C. B: 1 to 3 ratio (ECL2) at pH 7.4 and 15°C.C: 1 to 3 ratio
(ECL3) at pH 7.4 and 6°C in the presence of 5 mMTCEP. The values are corrected for the vol-
ume decrease upon ligand titration. Minor deviations from 1 can be explained by imperfectly
tuned pH and temperature. Error bars were calculated using Gaussian error propagation.
(EPS)
S10 Fig. ITC curves.Plots showing titration of ECLs into Nogo-A-Δ20. A: ECL2 titration into
Nogo-A-Δ20 showing only very small thermal heat exchanges. B: ECL3 addition to Nogo-A-
Δ20 shows only equally-sized heat signals throughout titration.
(EPS)
Acknowledgments
We thank Dr. Zorica Ristic for her expertise on Nogo-A-Δ20 expression and Dr. Jason Green-
wald for assistance with the CD spectrometer. We would also like to acknowledgeDr. Ilian Jele-
sarov for his assistance in ITCmeasurements.
Author Contributions
Conceived and designed the experiments:VZMEAMES RR.
Performed the experiments:VZMEA SB.
Analyzed the data:VZMEA SB RRMES.
Contributed reagents/materials/analysis tools:VZMEA SB MES RR.
Wrote the paper:VZMEA SBMES RR.
References
1. David S, Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous
system injury in adult rats. Science. 1981; 214(4523):931–3. Epub 1981/11/20.PMID: 6171034.
2. SchwabME, ThoenenH. Dissociated neurons regenerate into sciatic but not optic nerve explants in
culture irrespective of neurotrophic factors. The Journal of neuroscience: the official journal of the Soci-
ety for Neuroscience. 1985; 5(9):2415–23. PMID: 4032004.
NMRStudies on a Nogo Fragment
PLOSONE | DOI:10.1371/journal.pone.0161813 September 9, 2016 15 / 19
3. SchwabME, Caroni P. Oligodendrocytes and CNSmyelin are nonpermissive substrates for neurite
growth and fibroblast spreading in vitro. The Journal of neuroscience: the official journal of the Society
for Neuroscience. 1988; 8(7):2381–93.
4. ChenMS, Huber AB, van der Haar ME, Frank M, Schnell L, SpillmannAA, et al. Nogo-A is a myelin-
associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000; 403
(6768):434–9.
5. GrandPre T, Nakamura F, Vartanian T, StrittmatterSM. Identification of the Nogo inhibitor of axon
regenerationas a Reticulon protein. Nature. 2000; 403(6768):439–44.
6. PrinjhaR, Moore SE, VinsonM, Blake S, MorrowR, ChristieG, et al. Inhibitor of neurite outgrowth in
humans. Nature. 2000; 403(6768):383–4.
7. OertleT, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, et al. Nogo-A inhibits neurite
outgrowth and cell spreadingwith three discrete regions. The Journal of neuroscience: the official jour-
nal of the Society for Neuroscience. 2003; 23(13):5393–406. Epub 2003/07/05.PMID: 12843238.
8. Dodd DA, Niederoest B, BloechlingerS, Dupuis L, Loeffler JP, Schwab ME. Nogo-A, -B, and -C are
found on the cell surface and interact together in many different cell types. The Journal of biological
chemistry. 2005; 280(13):12494–502. Epub 2005/01/11. doi: 10.1074/jbc.M411827200 PMID:
15640160.
9. Tews B, Schonig K, Arzt ME, Clementi S, Rioult-Pedotti MS, ZemmarA, et al. SyntheticmicroRNA-
mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity
and cognitive function. Proceedings of the National Academy of Sciences of the United States of Amer-
ica. 2013; 110(16):6583–8. doi: 10.1073/pnas.1217665110 PMID: 23576723; PubMedCentral PMCID:
PMC3631667.
10. SchwabME. Functions of Nogo proteins and their receptors in the nervous system. Nature reviews
Neuroscience. 2010; 11(12):799–811.
11. Voeltz GK, PrinzWA, Shibata Y, Rist JM, RapoportTA. A class of membrane proteins shaping the
tubular endoplasmic reticulum.Cell. 2006; 124(3):573–86. Epub 2006/02/14. doi: 10.1016/j.cell.2005.
11.047 PMID: 16469703.
12. Kempf A, Tews B, Arzt ME,WeinmannO, Obermair FJ, Pernet V, et al. The sphingolipid receptor
S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. PLoS biology. 2014; 12(1):e1001763.
doi: 10.1371/journal.pbio.1001763 PMID: 24453941
13. Thiede-StanNK, Tews B, Albrecht D, Ristic Z, Ewers H, SchwabME. Tetraspanin-3 is an organizer of
the multi-subunit Nogo-A signaling complex. Journal of cell science. 2015. doi: 10.1242/jcs.167981
PMID: 26290381.
14. Fournier AE, GrandPre T, StrittmatterSM. Identification of a receptormediatingNogo-66 inhibition of
axonal regeneration. Nature. 2001; 409(6818):341–6. Epub 2001/02/24. doi: 10.1038/35053072 PMID:
11201742.
15. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-recep-
tor for Nogo, MAG andOMgp. Nature. 2002; 420(6911):74–8. Epub 2002/11/08. doi: 10.1038/
nature01176 PMID: 12422217.
16. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, et al. TAJ/TROY, an orphanTNF
receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron. 2005;
45(3):353–9. Epub 2005/02/08. doi: 10.1016/j.neuron.2004.12.050 PMID: 15694322.
17. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He XL, et al. A TNF receptor family member, TROY, is a
coreceptorwith Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron. 2005; 45
(3):345–51.Epub 2005/02/08. doi: 10.1016/j.neuron.2004.12.040PMID: 15694321.
18. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, et al. LINGO-1 is a component of the Nogo-66 receptor/p75
signaling complex. Nature neuroscience. 2004; 7(3):221–8. Epub 2004/02/18. doi: 10.1038/nn1188
PMID: 14966521.
19. Vasudevan SV, Schulz J, Zhou C, CoccoMJ. Protein folding at the membrane interface, the structure
of Nogo-66 requires interactionswith a phosphocholine surface. Proceedings of the National Academy
of Sciences of the United States of America. 2010; 107(15):6847–51.
20. Li M, Song J. The N- and C-terminiof the humanNogomolecules are intrinsically unstructured: bioinfor-
matics, CD, NMR characterization, and functional implications. Proteins. 2007; 68(1):100–8. Epub
2007/04/03. doi: 10.1002/prot.21385PMID: 17397058.
21. Li M, Shi J, Wei Z, Teng FY, Tang BL, Song J. Structural characterization of the humanNogo-A func-
tional domains. Solution structureof Nogo-40, a Nogo-66 receptor antagonist enhancing injured spinal
cord regeneration. European journal of biochemistry / FEBS. 2004; 271(17):3512–22. Epub 2004/08/
20. doi: 10.1111/j.0014-2956.2004.04286.xPMID: 15317586.
NMRStudies on a Nogo Fragment
PLOSONE | DOI:10.1371/journal.pone.0161813 September 9, 2016 16 / 19
22. Jones DT. Protein secondary structureprediction based on position-specific scoringmatrices. Journal
of molecular biology. 1999; 292(2):195–202. Epub 1999/09/24. doi: 10.1006/jmbi.1999.3091PMID:
10493868.
23. Gal M, Edmonds KA, Milbradt AG, Takeuchi K, Wagner G. Speeding up direct (15)N detection: hCaN
2D NMR experiment. J Biomol NMR. 2011; 51(4):497–504. doi: 10.1007/s10858-011-9580-7 PMID:
22038648
24. WishartDS, Sykes BD. The 13C chemical-shift index: a simplemethod for the identification of protein
secondary structureusing 13C chemical-shift data. J Biomol NMR. 1994; 4(2):171–80. PMID: 8019132
25. Marsh JA, Singh VK, Jia Z, Forman-Kay JD. Sensitivity of secondary structurepropensities to
sequence differences between alpha- and gamma-synuclein: implications for fibrillation.Protein sci-
ence: a publication of the Protein Society. 2006; 15(12):2795–804. doi: 10.1110/ps.062465306PMID:
17088319; PubMed Central PMCID: PMC2242444.
26. Novacek J, Zidek L, Sklenar V. Toward optimal-resolutionNMR of intrinsically disordered proteins. J
MagnReson. 2014; 241:41–52. doi: 10.1016/j.jmr.2013.12.008 PMID: 24656079
27. Mittag T, Forman-Kay JD. Atomic-level characterization of disorderedprotein ensembles. Current opin-
ion in structural biology. 2007; 17(1):3–14. doi: 10.1016/j.sbi.2007.01.009 PMID: 17250999
28. Rezaei-Ghaleh N, BlackledgeM, ZweckstetterM. Intrinsically disordered proteins: from sequence and
conformational properties toward drug discovery. Chembiochem: a European journal of chemical biol-
ogy. 2012; 13(7):930–50. doi: 10.1002/cbic.201200093PMID: 22505141
29. Plaxco KW, MortonCJ, GrimshawSB, Jones JA, Pitkeathly M, Campbell ID, et al. The effects of guani-
dine hydrochloride on the 'randomcoil' conformations and NMR chemical shifts of the peptide series
GGXGG. J Biomol NMR. 1997; 10(3):221–30.
30. LamSL, Hsu VL. NMR identification of left-handed polyproline type II helices. Biopolymers. 2003; 69
(2):270–81.doi: 10.1002/bip.10354 PMID: 12767128
31. Eliezer D, Yao J, Dyson HJ, Wright PE. Structural and dynamic characterization of partially folded
states of apomyoglobin and implications for protein folding. Nature structural biology. 1998; 5(2):148–
55. PMID: 9461081.
32. Clore GM, Driscoll PC, Wingfield PT, Gronenborn AM. Analysis of the backbone dynamics of interleu-
kin-1 beta using two-dimensional inverse detected heteronuclear 15N-1HNMR spectroscopy. Bio-
chemistry. 1990; 29(32):7387–401. PMID: 2223770
33. MukraschMD, Bibow S, Korukottu J, Jeganathan S, Biernat J, GriesingerC, et al. Structural polymor-
phism of 441-residue tau at single residue resolution.PLoS biology. 2009; 7(2):e34.Epub 2009/02/20.
doi: 10.1371/journal.pbio.1000034 PMID: 19226187; PubMedCentral PMCID: PMC2642882.
34. OldfieldCJ, Dunker AK. Intrinsicallydisordered proteins and intrinsically disordered protein regions.
Annual review of biochemistry. 2014; 83:553–84. doi: 10.1146/annurev-biochem-072711-164947
PMID: 24606139.
35. Zander H, Hettich E, Greiff K, Chatwell L, Skerra A. Biochemical characterization of the recombinant
humanNogo-A ectodomain. The FEBS journal. 2007; 274(10):2603–13. Epub 2007/04/18. doi: 10.
1111/j.1742-4658.2007.05796.x PMID: 17437522.
36. ZhengG, Stait-GardnerT, Anil Kumar PG, Torres AM, PriceWS. PGSTE-WATERGATE: an STE-
based PGSENMR sequencewith excellent solvent suppression. J MagnReson. 2008; 191(1):159–63.
Epub 2007/12/19. doi: 10.1016/j.jmr.2007.12.001 PMID: 18086542.
37. Schmandke A, Schmandke A, PietroMA, SchwabME. An open source based high content screening
method for cell biology laboratories investigating cell spreading and adhesion. PloS one. 2013; 8(10):
e78212. doi: 10.1371/journal.pone.0078212PMID: 24205161; PubMedCentral PMCID: PMC3804740.
38. BerlowRB, Dyson HJ, Wright PE. Functional advantages of dynamic protein disorder. FEBS letters.
2015. Epub 2015/06/16. doi: 10.1016/j.febslet.2015.06.003PMID: 26073260.
39. Tompa P. The functional benefits of protein disorder. Journal of Molecular Structure: THEOCHEM.
2003;666–667:361–71. http://dx.doi.org/10.1016/j.theochem.2003.08.047.
40. Uversky VN. Intrinsic disorder-based protein interactions and their modulators. Current pharmaceutical
design. 2013; 19(23):4191–213. Epub 2012/11/23. PMID: 23170892.
41. Dunker AK, Bondos SE, Huang F, Oldfield CJ. Intrinsically disorderedproteins andmulticellular organ-
isms. Seminars in cell & developmental biology. 2015; 37:44–55. doi: 10.1016/j.semcdb.2014.09.025
PMID: 25307499.
42. Hu F, StrittmatterSM. The N-terminaldomain of Nogo-A inhibits cell adhesion and axonal outgrowth by
an integrin-specificmechanism. The Journal of neuroscience: the official journal of the Society for Neu-
roscience. 2008; 28(5):1262–9.
NMRStudies on a Nogo Fragment
PLOSONE | DOI:10.1371/journal.pone.0161813 September 9, 2016 17 / 19
43. Shypitsyna A, Malaga-Trillo E, Reuter A, StuermerCA. Origin of Nogo-A by domain shuffling in an early
jawed vertebrate.Molecular biology and evolution. 2011; 28(4):1363–70. Epub 2010/11/26. doi: 10.
1093/molbev/msq313PMID: 21098000.
44. Sumiyoshi K, Obayashi S, Tabunoki H, ArimaK, Satoh J. Proteinmicroarray analysis identifies cyclic
nucleotide phosphodiesterase as an interactor of Nogo-A. Neuropathology: official journal of the Japa-
nese Society of Neuropathology. 2010; 30(1):7–14. Epub 2009/06/11. doi: 10.1111/j.1440-1789.2009.
01035.x PMID: 19508346.
45. Qin H, Pu HX, Li M, Ahmed S, Song J. Identification and structuralmechanism for a novel interaction
between a ubiquitin ligaseWWP1 and Nogo-A, a key inhibitor for central nervous system regeneration.
Biochemistry. 2008; 47(51):13647–58. Epub 2008/11/28. doi: 10.1021/bi8017976 PMID: 19035836.
46. SchwabME, StrittmatterSM. Nogo limits neural plasticity and recovery from injury. Current opinion in
neurobiology. 2014; 27:53–60. doi: 10.1016/j.conb.2014.02.011 PMID: 24632308; PubMed Central
PMCID: PMC4122629.
47. Kempf A, SchwabME. Nogo-A represses anatomical and synaptic plasticity in the central nervous sys-
tem. Physiology. 2013; 28(3):151–63. Epub 2013/05/03. doi: 10.1152/physiol.00052.2012 PMID:
23636261.
48. Tompa P, Szasz C, Buday L. Structural disorder throws new light on moonlighting. Trends in biochemi-
cal sciences. 2005; 30(9):484–9. Epub 2005/08/02. doi: 10.1016/j.tibs.2005.07.008 PMID: 16054818.
49. Tompa P. The interplay between structureand function in intrinsically unstructured proteins. FEBS let-
ters. 2005; 579(15):3346–54. Epub 2005/06/10. doi: 10.1016/j.febslet.2005.03.072PMID: 15943980.
50. ZhangW, Ganguly D, Chen J. Residual structures, conformational fluctuations, and electrostatic inter-
actions in the synergistic folding of two intrinsically disordered proteins. PLoS computational biology.
2012; 8(1):e1002353. Epub 2012/01/19. doi: 10.1371/journal.pcbi.1002353 PMID: 22253588; PubMed
Central PMCID: PMC3257294.
51. Tsai CJ, Ma B, ShamYY, Kumar S, Nussinov R. Structured disorder and conformational selection. Pro-
teins. 2001; 44(4):418–27. Epub 2001/08/03.PMID: 11484219.
52. FuxreiterM, Simon I, Friedrich P, Tompa P. Preformedstructural elements feature in partner recogni-
tion by intrinsically unstructured proteins. Journal of molecular biology. 2004; 338(5):1015–26. Epub
2004/04/28. doi: 10.1016/j.jmb.2004.03.017 PMID: 15111064.
53. Song J, Guo LW, Muradov H, Artemyev NO, Ruoho AE, Markley JL. Intrinsically disorderedgamma-
subunit of cGMP phosphodiesterase encodes functionally relevant transient secondary and tertiary
structure.Proceedings of the National Academy of Sciences of the United States of America. 2008;
105(5):1505–10. Epub 2008/01/31. doi: 10.1073/pnas.0709558105 PMID: 18230733; PubMed Central
PMCID: PMC2234174.
54. Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, et al. Nogo-A antibody improves
regenerationand locomotion of spinal cord-injured rats. Annals of neurology. 2005; 58(5):706–19. doi:
10.1002/ana.20627 PMID: 16173073.
55. Freund P, Schmidlin E, Wannier T, Bloch J, Mir A, SchwabME, et al. Nogo-A-specific antibody treat-
ment enhances sprouting and functional recovery after cervical lesion in adult primates. Naturemedi-
cine. 2006; 12(7):790–2. doi: 10.1038/nm1436 PMID: 16819551.
56. Jerabek-WillemsenM,Wienken CJ, Braun D, Baaske P, Duhr S. Molecular interaction studies using
microscale thermophoresis. Assay and drug development technologies. 2011; 9(4):342–53. doi: 10.
1089/adt.2011.0380PMID: 21812660; PubMedCentral PMCID: PMC3148787.
57. Kay LE, IkuraM, Tschudin R, Bax A. Three-dimensional triple-resonance \NMR\ spectroscopy of isoto-
pically enrichedproteins. Journal of MagneticResonance (1969). 1990; 89(3):496–514. http://dx.doi.
org/10.1016/0022-2364(90)90333-5.
58. Grzesiek S, Bax A. An efficient experiment for sequential backbone assignment of medium-sized isoto-
pically enrichedproteins. Journal of MagneticResonance (1969). 1992; 99(1):201–7. http://dx.doi.org/
10.1016/0022-2364(92)90169-8.
59. Panchal SC, Bhavesh NS, Hosur RV. Improved 3D triple resonance experiments, HNN and HN(C)N,
for HN and 15N sequential correlations in (13C, 15N) labeled proteins: application to unfolded proteins.
J Biomol NMR. 2001; 20(2):135–47. PMID: 11495245
60. Kjaergaard M, Poulsen FM. Sequence correction of random coil chemical shifts: correlation between
neighbor correction factors and changes in the Ramachandran distribution. J Biomol NMR. 2011; 50
(2):157–65.doi: 10.1007/s10858-011-9508-2 PMID: 21604143
61. Permi P, Kilpelainen I, Annila A, Heikkinen S. Intensitymodulated HSQC and HMQC: two simplemeth-
ods to measure 3J(HNH)alpha in proteins. J Biomol NMR. 2000; 16(1):29–37. PMID: 10718610
NMRStudies on a Nogo Fragment
PLOSONE | DOI:10.1371/journal.pone.0161813 September 9, 2016 18 / 19
62. Farrow NA, MuhandiramR, Singer AU, Pascal SM, Kay CM, Gish G, et al. Backbone dynamics of a
free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Bio-
chemistry. 1994; 33(19):5984–6003. PMID: 7514039.
63. Chou JJ, Baber JL, Bax A. Characterization of phospholipid mixed micelles by translational diffusion. J
Biomol NMR. 2004; 29(3):299–308. Epub 2004/06/24. doi: 10.1023/B:JNMR.0000032560.43738.6a
PMID: 15213428.
64. Mills R. Self-diffusion in normal and heavy water in the range 1-45.deg. The Journal of Physical Chem-
istry. 1973; 77(5):685–8. doi: 10.1021/j100624a025
65. Zar JH. Biostatistical analysis. Fourth ed. Upper Saddle River, New Jersey: PrenticeHall; 1999.
66. WilliamsonMP. Using chemical shift perturbationto characterise ligand binding. Prog Nucl Magn
Reson Spectrosc. 2013; 73:1–16. doi: 10.1016/j.pnmrs.2013.02.001 PMID: 23962882
67. VrankenWF, BoucherW, Stevens TJ, Fogh RH, Pajon A, LlinasM, et al. The CCPN datamodel for
NMR spectroscopy: development of a software pipeline. Proteins. 2005; 59(4):687–96. doi: 10.1002/
prot.20449PMID: 15815974
68. Kamentsky L, Jones TR, Fraser A, Bray MA, LoganDJ, MaddenKL, et al. Improved structure, function
and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics.
2011; 27(8):1179–80. doi: 10.1093/bioinformatics/btr095PMID: 21349861; PubMedCentral PMCID:
PMC3072555.
NMRStudies on a Nogo Fragment
PLOSONE | DOI:10.1371/journal.pone.0161813 September 9, 2016 19 / 19
